Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Polaryx Therapeutics, Inc. - Common Stock (NQ:PLYX)

4.910 +0.030 (+0.61%)

Streaming Delayed Price Updated: 9:30 AM EDT, May 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	7,745
Open	4.880
Bid (Size)	4.880 (1,000)
Ask (Size)	4.960 (100)
Prev. Close	4.880
Today's Range	4.880 - 4.940
52wk Range	2.201 - 48.91
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference

April 23, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

April 21, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Performance

YTD	-86.0%	-86.0%
1 Month	-31.2%	-31.2%
3 Month	-86.0%	-86.0%
6 Month	-86.0%	-86.0%
1 Year	-86.0%	-86.0%

More News

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care

April 15, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference

April 01, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)

March 17, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Therapeutics Deepens Engagement with the Krabbe Disease Community Through Scientific and Patient Advocacy Events

March 12, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Battered Polaryx Stock Turns Retail-Trader Heads After 70% Surge: What’s Behind The Sudden Interest? ↗

March 11, 2026

Via Stocktwits

Polaryx Therapeutics Marks Rare Disease Day, Reaffirming Commitment to Patients with Rare Pediatric Lysosomal Storage Disorders

February 27, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

What's Going On With Polaryx Therapeutics Stock Wednesday? ↗

February 18, 2026

Via Benzinga

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans ↗

February 17, 2026

Via Benzinga

Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial

February 17, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™

February 10, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx Therapeutics Welcomes New Members of the Board of Directors

February 05, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

February 03, 2026

From Polaryx Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Polaryx Therapeutics, Inc. - Common Stock publicly traded?

Yes, Polaryx Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Polaryx Therapeutics, Inc. - Common Stock trade on?

Polaryx Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Polaryx Therapeutics, Inc. - Common Stock?

The ticker symbol for Polaryx Therapeutics, Inc. - Common Stock is PLYX on the Nasdaq Stock Market

What is the current price of Polaryx Therapeutics, Inc. - Common Stock?

The current price of Polaryx Therapeutics, Inc. - Common Stock is 4.910

When was Polaryx Therapeutics, Inc. - Common Stock last traded?

The last trade of Polaryx Therapeutics, Inc. - Common Stock was at 05/04/26 09:30 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.